Researchers Believe They Found A Zika Virus Treatment And It’s Already Out in the Market

    A drug that can prevent Zika virus from spreading inside the body was recently revealed to be already out in the market by a group of researchers.

    Scientists from Florida State University, Johns Hopkins University and the National Institutes of Health made the discovery that there are existing drug compounds that not only can stop Zika from further replicating in the patient’s system but can also help avoid damaging the fetal brain cells that lead to birth defects in offspring.

    Interestingly, one of the drugs is reportedly already out on the market and is currently being sold as a treatment for tapeworm, reports Florida State University News.

    “We focused on compounds that have the shortest path to clinical use,” said FSU Professor of Biological Science Hengli Tang in their report published on Monday by Nature Medicine“This is a first step toward a therapeutic that can stop transmission of this disease.”

    Tang and the team of researchers have identified two different groups of compounds that have the potential to be used for Zika treatment.

    A U.S. Food and Drug Administration approved drug called Nicolsamide, the drug used to treat tapeworms, is based on one of these compounds.

    Further tests may be required, however, in determining the treatment method to use for the viral infection before the drug can be prescribed by any doctor.

    Tang, along with Johns Hopkins Professors Guo-Li Ming and Hongjun Song and National Institutes of Health scientist Wei Zheng, got in contact in January because Tang, a virologist, was able to secure a sample of the virus, while Ming and Song, neurologists, had cortical stem cells that scientists needed for testing.

    Working together, the group was recognized for their work that showed the virus caused the severe birth defect that causes babies to be born with a much smaller head and brain.

    Zheng, an expert on drug compounds, helped the team sift through 6,000 compounds that are already approved or are in the process of being approved by the FDA to find a potential cure and treatment for Zika.

    The strategy in looking for a medicine already out in the market could be made more available quicker to those infected by the virus.

    “It takes years if not decades to develop a new drug,” Song said. “In this sort of global health emergency, we don’t have time. So instead of using new drugs, we chose to screen existing drugs. In this way, we hope to create a therapy much more quickly.”

    The research team is currently working on the compounds and is hoping to begin testing the drugs on animals infected with Zika.

    Support our Journalism with a Contribution

    Many people might not know this, but despite our large and loyal following which we are immensely grateful for, NextShark is still a small bootstrapped startup that runs on no outside funding or loans.

    Everything you see today is built on the backs of warriors who have sacrificed opportunities to help give Asians all over the world a bigger voice.

    However, we still face many trials and tribulations in our industry, from figuring out the most sustainable business model for independent media companies to facing the current COVID-19 pandemic decimating advertising revenues across the board.

    We hope you consider making a contribution so we can continue to provide you with quality content that informs, educates and inspires the Asian community. Even a $1 contribution goes a long way.  Thank you for everyone's support. We love you all and can't appreciate you guys enough.

    Support NextShark

    Mastercard, Visa, Amex, Discover, Paypal